Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.
Clinical trial NCT03140332 · COMPLETED
Trial details
- NCT number
- NCT03140332
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-27
- Primary completion
- 2020-02-27
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.